Adamas Pharmaceuticals, Inc.

/Adamas Pharmaceuticals, Inc.

Adamas is a pharmaceutical company committed to developing and commercializing products and product candidates for the treatment of chronic neurological disorders.

Symbol

Last Closing Price
$42.65

Shares
2,100,000

Effective Date
January 24, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange